Stock FMS FRESENIUS MEDICAL CARE AG
Add to a list
To use this feature you must be a member
Log inSign up

Financials Fresenius Medical Care AG Nyse

Equities

FMS

US3580291066

Healthcare Facilities & Services

Market Closed - Nyse
Other stock markets
 01:00:02 2024-07-03 pm EDT 		5-day change 1st Jan Change
19.23 USD +0.37% Intraday chart for Fresenius Medical Care AG +0.68% -7.68%
Jun. 19 FMC FRESENIUS MEDICAL CARE AG & CO KGAA : UBS sticks Neutral ZD
Jun. 14 FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Sell rating from Jefferies ZD

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 19,672 19,974 16,742 8,970 11,138 10,448 - -
Enterprise Value (EV) 1 32,447 31,272 28,580 20,909 21,898 20,306 19,436 18,481
P/E ratio 16.7 x 17.2 x 17.3 x 13.3 x 22.3 x 15.7 x 10.8 x 9 x
Yield 1.82% 1.96% 2.36% 3.66% 3.13% 2.97% 3.68% 4.19%
Capitalization / Revenue 1.13 x 1.12 x 0.95 x 0.46 x 0.57 x 0.53 x 0.51 x 0.49 x
EV / Revenue 1.86 x 1.75 x 1.62 x 1.08 x 1.13 x 1.04 x 0.96 x 0.87 x
EV / EBITDA 8.4 x 7.65 x 8.22 x 6.24 x 7.02 x 6.04 x 5.22 x 4.62 x
EV / FCF 22.5 x 9.78 x 17.2 x 14.1 x 11.2 x 11.2 x 10.1 x 10.1 x
FCF Yield 4.44% 10.2% 5.81% 7.08% 8.95% 8.93% 9.88% 9.87%
Price to Book 1.67 x 1.78 x 1.32 x 0.64 x 0.75 x 0.74 x 0.71 x 0.68 x
Nbr of stocks (in thousands) 298,249 292,869 292,994 293,413 293,413 293,413 - -
Reference price 2 65.96 68.20 57.14 30.57 37.96 35.61 35.61 35.61
Announcement Date 2/20/20 2/23/21 2/22/22 2/21/23 2/20/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 17,477 17,859 17,619 19,398 19,454 19,560 20,299 21,163
EBITDA 1 3,863 4,090 3,476 3,350 3,121 3,363 3,726 4,002
EBIT 1 2,270 2,304 1,852 1,512 1,369 1,660 2,054 2,310
Operating Margin 12.99% 12.9% 10.51% 7.79% 7.04% 8.49% 10.12% 10.91%
Earnings before Tax (EBT) 1 1,841 1,936 1,572 1,219 1,033 1,210 1,644 1,901
Net income 1 1,200 1,164 969.3 673.4 499 665.3 964.1 1,156
Net margin 6.87% 6.52% 5.5% 3.47% 2.57% 3.4% 4.75% 5.46%
EPS 2 3.960 3.960 3.310 2.300 1.700 2.266 3.292 3.955
Free Cash Flow 1 1,442 3,197 1,660 1,480 1,960 1,813 1,920 1,825
FCF margin 8.25% 17.9% 9.42% 7.63% 10.08% 9.27% 9.46% 8.62%
FCF Conversion (EBITDA) 37.33% 78.17% 47.76% 44.18% 62.8% 53.91% 51.53% 45.59%
FCF Conversion (Net income) 120.18% 274.57% 171.26% 219.78% 392.79% 272.51% 199.17% 157.85%
Dividend per Share 2 1.200 1.340 1.350 1.120 1.190 1.057 1.311 1.494
Announcement Date 2/20/20 2/23/21 2/22/22 2/21/23 2/20/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 4,647 4,548 4,757 5,096 4,997 4,704 4,825 4,936 4,988 4,725 5,019 5,130 5,737 4,031 6,046
EBITDA 1 895.4 767 763 973.6 846.6 698.8 790.8 778.3 854 758.4 750.5 778.1 863.2 -95.22 1,920
EBIT 1 449.2 348 341 471.6 351.9 260.9 357 324 428 246 430.8 456.1 593.2 -485.5 1,530
Operating Margin 9.67% 7.65% 7.17% 9.25% 7.04% 5.55% 7.4% 6.56% 8.58% 5.21% 8.58% 8.89% 10.34% -12.05% 25.3%
Earnings before Tax (EBT) 382.4 278.6 268.9 395.2 - - - - - - - - - - -
Net income 1 228.7 157 147 230.1 138.8 86.36 140 84 188 71 959 959 -617.8 -780.2 1,235
Net margin 4.92% 3.45% 3.09% 4.52% 2.78% 1.84% 2.9% 1.7% 3.77% 1.5% 19.11% 18.7% -10.77% -19.36% 20.43%
EPS 2 0.7800 0.5400 0.5000 0.7800 0.4800 0.2900 0.4800 0.2900 0.6400 0.2400 13.07 13.07 -8.422 - -
Dividend per Share 2 1.350 - - - 1.120 - - - 1.190 - - - 0.7372 - -
Announcement Date 2/22/22 5/4/22 7/28/22 10/31/22 2/21/23 5/9/23 8/2/23 11/1/23 2/20/24 5/7/24 - - - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 12,775 11,298 11,838 11,939 10,760 9,857 8,988 8,032
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 3.307 x 2.762 x 3.406 x 3.564 x 3.448 x 2.931 x 2.412 x 2.007 x
Free Cash Flow 1 1,442 3,197 1,660 1,480 1,960 1,813 1,920 1,825
ROE (net income / shareholders' equity) 11.5% 11.7% 7.37% 5.05% 4.99% 5.58% 6.99% 7.8%
ROA (Net income/ Total Assets) 4.06% 3.6% 2.93% 1.92% 2.17% 2% 2.69% 3.31%
Assets 1 29,589 32,308 33,038 35,060 22,998 33,299 35,827 34,967
Book Value Per Share 2 39.50 38.30 43.30 47.70 50.50 48.20 50.00 52.40
Cash Flow per Share 2 8.480 14.40 8.500 7.390 8.960 6.660 7.270 7.740
Capex 1 1,125 1,036 829 687 669 859 915 1,007
Capex / Sales 6.44% 5.8% 4.71% 3.54% 3.44% 4.39% 4.51% 4.76%
Announcement Date 2/20/20 2/23/21 2/22/22 2/21/23 2/20/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
35.61 EUR
Average target price
39.97 EUR
Spread / Average Target
+12.25%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+20.64% 85.53B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-28.19% 71.18B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
-0.07% 26.41B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
+1.82% 17.32B
LABCORP HOLDINGS INC. Stock Labcorp Holdings Inc.
-10.31% 17.18B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+2.19% 15.65B
NATERA, INC. Stock Natera, Inc.
+78.22% 13.71B
TENET HEALTHCARE CORPORATION Stock Tenet Healthcare Corporation
+79.75% 13.27B
PURE HEALTH HOLDING Stock Pure Health Holding
-23.68% 13.28B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. FME Stock
  4. FMS Stock
  5. Financials Fresenius Medical Care AG